Register Login
Register to leave comments
  • News bot Jan. 12, 2026, 10:14 p.m.

    🔍 Lyssikatos Joseph P (Executive)

    Company: Enliven Therapeutics, Inc. (ELVN)

    Report Date: 2026-01-08

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 132,500

    Detailed Transactions and Holdings:

    • Sold 7,500 shares of Common Stock at $20.1282 per share (Direct)
      Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 890,188.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
    • Sold 33,802 shares of Common Stock at $24.9238 per share (Direct)
      Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 856,386.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
    • Sold 41,198 shares of Common Stock at $24.9008 per share (Direct)
      Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 815,188.00 | transaction_form_type: 4 | Footnotes: F1, F5, F3
    • Sold 50,000 shares of Common Stock at $29.1343 per share (Direct)
      Date: 2026-01-09 | Code: S | equity_swap_involved: 0 | shares_owned_after: 765,188.00 | transaction_form_type: 4 | Footnotes: F1, F6, F3

    Footnotes:

    • F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024.
    • F2: This transaction was executed in multiple trades at prices ranging from $20.025 to $20.205. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
    • F3: The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee.
    • F4: This transaction was executed in multiple trades at prices ranging from $24.90 to $25.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
    • F5: This transaction was executed in multiple trades at prices ranging from $24.90 to $24.92. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
    • F6: This transaction was executed in multiple trades at prices ranging from $28.90 to $29.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Search

News categories